BeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024

SAN MATEO, Calif.–(BUSINESS WIRE)—- $BGNE #BeiGene–BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share new data from its hematology portfolio and pipeline at the European Hematology Association 2024 Hybrid Congress (EHA2024) in Madrid, Spain, June 13-16, 2024. BeiGene has 28 abstracts accepted at EHA2024, with four scheduled for oral presentations. “As part of our dedication to bringing high-quality therapies to patients around the world, our presen
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks